Rezolute, Inc. Profile Avatar - Palmy Investing

Rezolute, Inc.

Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibod…

Biotechnology
US, Redwood City [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of RZLT's Analysis
CIK: 1509261 CUSIP: 76200L309 ISIN: US76200L3096 LEI: - UEI: -
Secondary Listings
RZLT has no secondary listings inside our databases.